- For Some, ‘Tis the Season for Loneliness. Experts Offer Tips to Stay Connected
- Taking a GLP-1 Medication? Here’s Tips to Holiday Eating
- Bird Flu Virus in Canadian Teen Shows Mutations That Could Help It Spread Among Humans
- Flu, COVID Vaccination Rates Remain Low as Winter Nears
- ’10 Americas:’ Health Disparities Mean Life Expectancy Varies Across U.S.
- Short-Term Hormone Therapy for Menopause Won’t Harm Women’s Brains
- Could a Vitamin Be Effective Treatment for COPD?
- Woman Receives World’s First Robotic Double-Lung Transplant
- Flavored Vapes Behind Big Surge in U.S. E-Cigarette Sales
- Reading Beyond Headline Rare For Most on Social Media, Study Finds
Health Highlights: Nov. 17, 2016
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
HHS Expands List of Those Able to Prescribe Drug to Treat Opioid Addiction
Nurse practitioners and physician assistants will be allowed to prescribe medication to treat people addicted to opioids, the U.S. Department of Health and Human Services announced Wednesday.
The move is the latest in the effort to combat that opioid abuse epidemic in the country.
Nurse practitioners and physician assistants can immediately take the 24 hours of required training to prescribe buprenorphine to treat opioid addiction. Those who complete the training and seek to prescribe buprenorphine for up to 30 patients will be able to apply to do so beginning in early 2017.
Previously, only doctors could prescribe buprenorphine.
“Today’s action will provide even more access to medication-assisted treatment,” SAMHSA Principal Deputy Administrator Kana Enomoto said in an agency news release. “Allowing nurse practitioners and physician assistants to prescribe buprenorphine will greatly expand access to quality, evidence-based treatment methods for those most in need of assistance.”
HHS also plans to allow nurse practitioners and physician assistants who have prescribed at the 30 patient limit for one year to apply for a waiver to prescribe buprenorphine for up to 100 patients.
—–
Engineer in N.J Train Crash Had Undiagnosed Sleep Apnea: Lawyer
The engineer of a New Jersey commuter train that slammed into the Hoboken Terminal had undiagnosed severe sleep apnea, according to his lawyer.
Engineer Thomas Gallagher recently learned he had severe sleep apnea, and the test results were sent to federal officials on Oct. 31, lawyer Jack Arseneault said Wednesday, The New York Times reported.
Gallagher has told officials he did not remember the September crash, and believes his sleep apnea might explain what happened, Arseneault said.
The crash killed one person and injured more than 100 others. Officials have said the train suddenly accelerated just before the crash, The Times reported.
—–
Grated Cheese Products Recalled by 4C Foods
Possible salmonella contamination has led to the recall of eight types of grated cheese products from 4C Foods Corp of Brooklyn, N.Y.
Six of the products are sold under the 4C brand names and two under the Cento brand name. No illnesses associated with the recalled products have been reported, according to the company.
The products were produced at the company’s Brooklyn facility before November 12 and sold nationwide. They have “Best By” dates between November 12, 2016, and November 12, 2018.
For more information, consumers can call the company toll-free at 1-866-969-1920.
Copyright © 2024 HealthDay. All rights reserved.